Phototoxicity of the Ethanolic Extract of


Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 11 07 2024
revised: 25 07 2024
accepted: 26 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

Acne is one of the most common dermatological conditions, peaking during adolescence and early adulthood, affecting about 85% of individuals aged 12-24. Although often associated with teenage years, acne can occur at any age, impacting over 25% of women and 12% of men in their forties. Treatment strategies vary depending on the severity, including the use of topical gels or creams containing benzoyl peroxide and retinoids, antibiotics, and systemic or topical isotretinoin. However, these treatments can cause irritation, allergies, and other toxic side effects. Currently, there is no natural-based alternative for antibacterial photodynamic therapy targeting acne using marine drugs or extracts. Through a bioguided screening approach, we identified the ethanol extract of

Identifiants

pubmed: 39195459
pii: md22080343
doi: 10.3390/md22080343
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institut Français de la Mer
ID : IFREMER INOCEAN innovation programme

Auteurs

Jean-Baptiste Bérard (JB)

French Research Institute for Exploitation of the Sea (IFREMER), PHYTOX, 44000 Nantes, France.

Tan-Sothea Ouk (TS)

Laboratoire des Agroressources, Biomolécules et Chimie pour l'Innovation en Santé (LABCiS), University of Limoges, UR 22722, 87000 Limoges, France.

Vincent Sol (V)

Laboratoire des Agroressources, Biomolécules et Chimie pour l'Innovation en Santé (LABCiS), University of Limoges, UR 22722, 87000 Limoges, France.

Louise Lefoulon (L)

French Research Institute for Exploitation of the Sea (IFREMER), PHYTOX, 44000 Nantes, France.

Cornelia Landolt (C)

Laboratoire des Agroressources, Biomolécules et Chimie pour l'Innovation en Santé (LABCiS), University of Limoges, UR 22722, 87000 Limoges, France.

Karine Grenier (K)

Laboratoire des Agroressources, Biomolécules et Chimie pour l'Innovation en Santé (LABCiS), University of Limoges, UR 22722, 87000 Limoges, France.

Naima Saad (N)

Laboratoire des Agroressources, Biomolécules et Chimie pour l'Innovation en Santé (LABCiS), University of Limoges, UR 22722, 87000 Limoges, France.

Elise Robert (E)

French Research Institute for Exploitation of the Sea (IFREMER), PHYTOX, 44000 Nantes, France.

Manoëlla Sibat (M)

French Research Institute for Exploitation of the Sea (IFREMER), PHYTOX, 44000 Nantes, France.

Nathalie Schreiber (N)

French Research Institute for Exploitation of the Sea (IFREMER), PHYTOX, 44000 Nantes, France.

Samuel Guenin (S)

QIMA Life Sciences, 86160 Gençay, France.

Laurent Picot (L)

UMR CNRS 7266 LIENSs, La Rochelle Université, 17042 La Rochelle, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH